SPRITAM Drug Patent Profile
✉ Email this page to a colleague
When do Spritam patents expire, and when can generic versions of Spritam launch?
Spritam is a drug marketed by Aprecia Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has twenty patent family members in nine countries.
The generic ingredient in SPRITAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-one suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Spritam
A generic version of SPRITAM was approved as levetiracetam by MYLAN on November 4th, 2008.
Summary for SPRITAM
International Patents: | 20 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 3,016 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SPRITAM |
What excipients (inactive ingredients) are in SPRITAM? | SPRITAM excipients list |
DailyMed Link: | SPRITAM at DailyMed |


Pharmacology for SPRITAM
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Anatomical Therapeutic Chemical (ATC) Classes for SPRITAM
US Patents and Regulatory Information for SPRITAM
SPRITAM is protected by five US patents.
Patents protecting SPRITAM
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Rapid disperse dosage form containing levetiracetam
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING LEVETIRACETAM
Rapid disperse dosage form containing levetiracetam
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING LEVETIRACETAM
Rapid disperse dosage form containing levetiracetam
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING LEVETIRACETAM UNDER FASTED CONDITIONS
Rapid disperse dosage form containing levetiracetam
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF ADMINISTERING LEVETIRACETAM UNDER FED CONDITIONS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-002 | Jul 31, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-003 | Jul 31, 2015 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SPRITAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-004 | Jul 31, 2015 | See Plans and Pricing | See Plans and Pricing |
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | See Plans and Pricing | See Plans and Pricing |
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-002 | Jul 31, 2015 | See Plans and Pricing | See Plans and Pricing |
Aprecia Pharms | SPRITAM | levetiracetam | TABLET, FOR SUSPENSION;ORAL | 207958-001 | Jul 31, 2015 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SPRITAM
See the table below for patents covering SPRITAM around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2908292 | See Plans and Pricing | |
European Patent Office | 0973507 | FORME GALENIQUE PRESENTANT DES PROPRIETES DE DISPERSION RAPIDE, SES PROCEDES D'UTILISATION ET SON PROCEDE DE PREPARATION (DOSAGE FORM EXHIBITING RAPID DISPERSE PROPERTIES, METHODS OF USE AND PROCESS FOR THE MANUFACTURE OF SAME) | See Plans and Pricing |
Japan | 5091910 | See Plans and Pricing | |
Japan | 6170234 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for SPRITAM
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0162036 | C300028 | Netherlands | See Plans and Pricing | PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929 |
0162036 | 2000C/032 | Belgium | See Plans and Pricing | PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |